FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
China Shineway Pharmaceutical Group Limited Stock AnalysisComprehensive stock analysis for China Shineway Pharmaceutical Group Limited (CSWYY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCSWYY
CSWYY
China Shineway Pharmaceutical Group Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CSWYY
Home🔹Stocks🔹China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited

CSWYY•OTC

China Shineway Pharmaceutical Group Limited

CSWYY•OTC
Market cap
$36.35M
Sentiment

Your view on CSWYY

Mkt Cap
$36.35M
Sentiment
Your view
CSWYY
China Shineway Pharmaceutical Group Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CSWYY
Company Overview

Overview

What the company does, where it operates, and who runs it.

About China Shineway Pharmaceutical Group Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Zhenjiang Li
Headquarters
No. 168 Shiluan Street, Shijiazhuang, CN
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Zhenjiang Li
Headquarters
No. 168 Shiluan Street, Shijiazhuang, CN
Description

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News